These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

232 related items for PubMed ID: 9649136

  • 1. Suppression of tumorigenic and metastatic potentials of human melanoma cell lines by mutated (143 Val-Ala) p53.
    Rauth S, Green A, Kichina J, Shilkaitis A.
    Br J Cancer; 1998 Jun; 77(12):2215-22. PubMed ID: 9649136
    [Abstract] [Full Text] [Related]

  • 2. Establishment of a human melanoma cell line lacking p53 expression and spontaneously metastasizing in nude mice.
    Rauth S, Kichina J, Green A, Bratescu L, Das Gupta TK.
    Anticancer Res; 1994 Jun; 14(6B):2457-63. PubMed ID: 7872667
    [Abstract] [Full Text] [Related]

  • 3. Adenovirus-mediated gene transfer of wild-type p53 results in melanoma cell apoptosis in vitro and in vivo.
    Cirielli C, Riccioni T, Yang C, Pili R, Gloe T, Chang J, Inyaku K, Passaniti A, Capogrossi MC.
    Int J Cancer; 1995 Nov 27; 63(5):673-9. PubMed ID: 7591284
    [Abstract] [Full Text] [Related]

  • 4. Dominant-negative CREB inhibits tumor growth and metastasis of human melanoma cells.
    Xie S, Price JE, Luca M, Jean D, Ronai Z, Bar-Eli M.
    Oncogene; 1997 Oct 23; 15(17):2069-75. PubMed ID: 9366524
    [Abstract] [Full Text] [Related]

  • 5. The melanoma differentiation-associated gene mda-6, which encodes the cyclin-dependent kinase inhibitor p21, is differentially expressed during growth, differentiation and progression in human melanoma cells.
    Jiang H, Lin J, Su ZZ, Herlyn M, Kerbel RS, Weissman BE, Welch DR, Fisher PB.
    Oncogene; 1995 May 04; 10(9):1855-64. PubMed ID: 7753561
    [Abstract] [Full Text] [Related]

  • 6. Transfection and expression of mutant p53 protein does not alter the in vivo or in vitro growth characteristics of the AA/C1 human adenoma derived cell line, including sensitivity to transforming growth factor-beta 1.
    Williams AC, Browne SJ, Manning AM, Daffada P, Collard TJ, Paraskeva C.
    Oncogene; 1994 May 04; 9(5):1479-85. PubMed ID: 8152811
    [Abstract] [Full Text] [Related]

  • 7. Wild-type p53 gene transfer inhibits invasion and reduces matrix metalloproteinase-2 levels in p53-mutated human melanoma cells.
    Toschi E, Rota R, Antonini A, Melillo G, Capogrossi MC.
    J Invest Dermatol; 2000 Jun 04; 114(6):1188-94. PubMed ID: 10844565
    [Abstract] [Full Text] [Related]

  • 8. p53 interference and growth inhibition in p53-mutant and overexpressing endometrial cancer cell lines.
    Janicek MF, Angioli R, Unal AD, Sevin BU, Madrigal M, Estape R, Averette HE.
    Gynecol Oncol; 1997 Jul 04; 66(1):94-102. PubMed ID: 9234928
    [Abstract] [Full Text] [Related]

  • 9. Mutant p53 can induce tumorigenic conversion of human bronchial epithelial cells and reduce their responsiveness to a negative growth factor, transforming growth factor beta 1.
    Gerwin BI, Spillare E, Forrester K, Lehman TA, Kispert J, Welsh JA, Pfeifer AM, Lechner JF, Baker SJ, Vogelstein B.
    Proc Natl Acad Sci U S A; 1992 Apr 01; 89(7):2759-63. PubMed ID: 1557382
    [Abstract] [Full Text] [Related]

  • 10. Stimulatory effect of reconstituted basement membrane components (matrigel) on the colony formation of a panel of human lung cancer cell lines in soft agar.
    Yoshida S, Shimizu E, Ogura T, Takada M, Sone S.
    J Cancer Res Clin Oncol; 1997 Apr 01; 123(6):301-9. PubMed ID: 9222295
    [Abstract] [Full Text] [Related]

  • 11. High-efficiency gene transfer and high-level expression of wild-type p53 in human lung cancer cells mediated by recombinant adenovirus.
    Zhang WW, Fang X, Mazur W, French BA, Georges RN, Roth JA.
    Cancer Gene Ther; 1994 Mar 01; 1(1):5-13. PubMed ID: 7621238
    [Abstract] [Full Text] [Related]

  • 12. Dominant-negative transcription factor AP-2 augments SB-2 melanoma tumor growth in vivo.
    Gershenwald JE, Sumner W, Calderone T, Wang Z, Huang S, Bar-Eli M.
    Oncogene; 2001 Jun 07; 20(26):3363-75. PubMed ID: 11423987
    [Abstract] [Full Text] [Related]

  • 13. Effects of inoculation site and Matrigel on growth and metastasis of human breast cancer cells.
    Bao L, Matsumura Y, Baban D, Sun Y, Tarin D.
    Br J Cancer; 1994 Aug 07; 70(2):228-32. PubMed ID: 8054270
    [Abstract] [Full Text] [Related]

  • 14. Overexpression of mutant p53 and c-erbB-2 proteins and breast tumour take in mice.
    Mehta RR, Graves JM, Warso MA, Das Gupta TK.
    Br J Cancer; 1995 Nov 07; 72(5):1160-4. PubMed ID: 7577462
    [Abstract] [Full Text] [Related]

  • 15. Wild-type p53 and a p53 temperature-sensitive mutant suppress human soft tissue sarcoma by enhancing cell cycle control.
    Pollock R, Lang A, Ge T, Sun D, Tan M, Yu D.
    Clin Cancer Res; 1998 Aug 07; 4(8):1985-94. PubMed ID: 9717829
    [Abstract] [Full Text] [Related]

  • 16. Bacterial redox protein azurin, tumor suppressor protein p53, and regression of cancer.
    Yamada T, Goto M, Punj V, Zaborina O, Chen ML, Kimbara K, Majumdar D, Cunningham E, Das Gupta TK, Chakrabarty AM.
    Proc Natl Acad Sci U S A; 2002 Oct 29; 99(22):14098-103. PubMed ID: 12393814
    [Abstract] [Full Text] [Related]

  • 17. Loss of AP-2 results in downregulation of c-KIT and enhancement of melanoma tumorigenicity and metastasis.
    Huang S, Jean D, Luca M, Tainsky MA, Bar-Eli M.
    EMBO J; 1998 Aug 03; 17(15):4358-69. PubMed ID: 9687504
    [Abstract] [Full Text] [Related]

  • 18. Mutant p53 melanoma cell lines respond differently to CP-31398-induced apoptosis.
    Ho CK, Li G.
    Br J Dermatol; 2005 Nov 03; 153(5):900-10. PubMed ID: 16225598
    [Abstract] [Full Text] [Related]

  • 19. [Effects of exogenous wild type p53 on malignant growth of human lung cancer cell line].
    Wang H, Lai B, Li J.
    Zhonghua Jie He He Hu Xi Za Zhi; 1998 May 03; 21(5):268-72. PubMed ID: 11326947
    [Abstract] [Full Text] [Related]

  • 20. Melanoma heterogeneity: differential, invasive, metastatic properties and profiles of cathepsin B, D and L activities in subclones of the B16F10-NEX2 cell line.
    Freitas ZF, Rodrigues EG, Oliveira V, Carmona AK, Travassos LR.
    Melanoma Res; 2004 Oct 03; 14(5):333-44. PubMed ID: 15457088
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.